Stelara

J&J psoriasis drug Stelara tames Crohn's disease in second trial
Yahoo/Reuters
Fri, 03/18/16 - 10:41 am
JNJ
psoriasis
Stelara
Crohn's Disease
Novartis' Cosentyx proves superior to Janssen's Stelara in head-to-head comparison
BioPharma Dive
Mon, 03/7/16 - 10:00 pm
Novartis
Cosentyx
Janssen
Stelara
psoriasis
J&J's Stelara succeeds in Phase III Crohn's disease trial
Yahoo/Reuters
Mon, 10/19/15 - 09:56 am
JNJ
Stelara
Crohn's Disease
clinical trials
Boehringer's psoriasis drug beats Stelara in head-to-head Phase II
Fierce Biotech
Fri, 10/9/15 - 10:36 am
Boehringer Ingelheim
JNJ
Stelara
psoriasis
BI 655066
Analyst: J&J's Stelara to challenge Novartis in ankylosing spondylitis
Fierce Pharma
Tue, 07/28/15 - 12:36 am
JNJ
Stelara
Novartis
ankylosing spondylitis
J&J's Stelara may be under fire in psoriasis, but it's positioned to score elsewhere
Fierce Pharma Marketing
Fri, 07/24/15 - 05:59 pm
JNJ
Stelara
psoriasis
Novartis
Cosentyx
Psoriasis data wars heat up at AAD with Novartis, Boehringer studies
Fierce Pharma Marketing
Thu, 03/26/15 - 07:38 am
Novartis
psoriasis
Boehringer Ingelheim
Pfizer
Xeljanz
Cosentyx
JNJ
Stelara
BI-655066
Amgen
AstraZeneca
Merck
Eli Lilly
Here comes the blockbuster: Novartis' Cosentyx bests Stelara in psoriasis trials
BioPharma Dive
Mon, 03/23/15 - 10:36 am
Novartis
Cosentyx
Stelara
psoriasis
Novartis AG (ADR) Cosentyx More Effective Than Johnson & Johnson Stelara
Bidness Etc.
Sat, 03/14/15 - 03:04 pm
Novartis
Cosentyx
Stelara
JNJ
psoriasis
Novartis psoriasis drug approval could upend market
Medical Marketing and Media
Thu, 01/22/15 - 09:55 am
Novartis
psoriasis
Cosentyx
Amgen
Stelara
Enbrel
Johnson & Johnson's Immunology Pipeline Is Golden
Seeking Alpha
Mon, 12/22/14 - 04:51 pm
JNJ
immunology
Stelara
sirukumab
CNTO 6785
Is this the future of late-stage drug development? Lets hope so!
Forbes
Mon, 12/15/14 - 10:19 am
R&D
drug development
Stelara
JNJ
psoriasis
Novartis
Cosentyx
Novartis AG and Amgen Inc. Take Aim at Johnson & Johnson
Motley Fool
Mon, 12/15/14 - 08:50 am
Novartis
Amgen
JNJ
Stelara
psoriasis
brodalumab
Cosentyx
Novartis' psoriasis drug tops J&J's Stelara as it speeds toward approval
Fierce Biotech
Fri, 12/12/14 - 08:51 am
Novartis
psoriasis
JNJ
Stelara
secukinumab
Amgen, AstraZeneca's brodalumab beats J&J's Stelara in 2nd PhIII psoriasis showdown
Fierce Biotech
Wed, 11/26/14 - 11:38 am
Amgen
AstraZeneca
brodalumab
JNJ
Stelara
psoriasis
Amgen psoriasis drug tops J&J's Stelara in Phase III study
Yahoo/Reuters
Wed, 11/12/14 - 08:32 am
Amgen
psoriasis
JNJ
brodalumab
Stelara
Sovaldi's not the only superhero launch: Meet the rest of the pharma Avengers
Fierce Pharma Marketing
Thu, 11/6/14 - 09:03 am
Sovaldi
Gilead Sciences
Eyelea
Tecfidera
Zytiga
Kalydeco
Vertex Pharmaceuticals
Victoza
Novo Nordisk
Gilenya
Yervoy
Xtandi
Stribild
Stelara
3 Drugs Critical to Johnson & Johnson's Future
Motley Fool
Tue, 10/21/14 - 09:20 am
JNJ
Olysio
Zytiga
Invega Sustenna
Xarelto
Stelara
Watch Out AbbVie, Here Comes Celgene
Motley Fool
Wed, 03/26/14 - 12:45 pm
Celgene
AbbVie
Humira
Stelara
Otezla
The Psoriatic Arthritis Race: Celgene Vs. Johnson & Johnson
Seeking Alpha
Mon, 01/20/14 - 03:08 pm
psoriatic arthritis
Celgene
JNJ
Otezla
Stelara
apremilast

Pages